Literature DB >> 12708488

Renal carcinogenesis: genotype, phenotype and dramatype.

Okio Hino1, Toshiyuki Kobayashi, Shuji Momose, Yasushi Kikuchi, Hiroyuki Adachi, Kazuo Okimoto.   

Abstract

Cancer is a heritable disorder of somatic cells. Environment and heredity are both important in the carcinogenic process. The Eker rat model of hereditary renal carcinoma (RC) is an example of a Mendelian dominantly inherited predisposition to a specific cancer in an experimental animal. Forty years after the discovery of the Eker rat in Oslo, we and Knudson's group independently identified a germline retrotransposon insertion in the rat homologue of the human tuberous sclerosis (TSC2) gene. To our knowledge, this was the first isolation of a Mendelian dominantly predisposing cancer gene in a naturally occurring animal model. Recently, we discovered a new hereditary renal carcinoma in the rat. This rat was named the "Nihon" rat and its predisposing (Nihon) gene could be a novel renal tumor suppressor gene. This article will review the utility of these unique models for the study of problems in carcinogenesis; e.g., species-specific differences in tumorigenesis, cell stage and tissue/cell-type specific tumorigenesis, multistep carcinogenesis, modifier gene(s) in renal carcinogenesis, cancer prevention and the development of therapeutic treatments which can be translated to human patients, as well as how environmental factors interact with cancer susceptibility gene(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708488     DOI: 10.1111/j.1349-7006.2003.tb01410.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population.

Authors:  Wani Arjumand; Shiekh Tanveer Ahmad; Amlesh Seth; Ashish Kumar Saini; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-09-20

2.  Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Authors:  Kazim Sahin; Brian Cross; Nurhan Sahin; Karina Ciccone; Shadeah Suleiman; Adeboye O Osunkoya; Viraj Master; Wayne Harris; Bradley Carthon; Ramzi Mohammad; Birdal Bilir; Karin Wertz; Carlos S Moreno; Cheryl L Walker; Omer Kucuk
Journal:  Arch Biochem Biophys       Date:  2015-01-17       Impact factor: 4.013

3.  Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.

Authors:  Elena A Goncharova; Dmitry A Goncharov; Gautam Damera; Omar Tliba; Yassine Amrani; Reynold A Panettieri; Vera P Krymskaya
Journal:  Mol Pharmacol       Date:  2009-07-13       Impact factor: 4.436

4.  Spontaneous occurrence of a distinctive renal tubule tumor phenotype in rat carcinogenicity studies conducted by the national toxicology program.

Authors:  Gordon C Hard; John Curtis Seely; Grace E Kissling; Laura J Betz
Journal:  Toxicol Pathol       Date:  2008-04-25       Impact factor: 1.902

Review 5.  Environmental carcinogenesis - 100th anniversary of creating cancer.

Authors:  Misa Imai; Okio Hino
Journal:  Cancer Sci       Date:  2015-10-21       Impact factor: 6.716

6.  Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in Eker rats.

Authors:  Tatsuya Inoue; Toshiaki Kokubo; Kazuhiro Daino; Hiromi Yanagihara; Fumiko Watanabe; Chizuru Tsuruoka; Yoshiko Amasaki; Takamitsu Morioka; Shino Homma-Takeda; Toshiyuki Kobayashi; Okio Hino; Yoshiya Shimada; Shizuko Kakinuma
Journal:  Cancer Sci       Date:  2020-02-03       Impact factor: 6.716

7.  Vitamin d pathway genes, diet, and risk of renal cell carcinoma.

Authors:  S Karami; P Brennan; M Navratilova; D Mates; D Zaridze; V Janout; H Kollarova; V Bencko; V Matveev; N Szesznia-Dabrowska; I Holcatova; M Yeager; S Chanock; N Rothman; P Boffetta; W-H Chow; L E Moore
Journal:  Int J Endocrinol       Date:  2009-11-05       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.